
Procaps Group S.A (PROC) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2023Income Metrics
Revenue
118.4M
Gross Profit
68.4M
57.77%
Operating Income
13.0M
11.02%
Net Income
8.2M
6.92%
EPS (Diluted)
$0.08
Balance Sheet Metrics
Total Assets
498.6M
Total Liabilities
460.1M
Shareholders Equity
38.5M
Debt to Equity
11.96
Cash Flow Metrics
Operating Cash Flow
35.6M
Free Cash Flow
39.7M
Revenue & Profitability Trend
Procaps Group S.A Income Statement From 2019 to 2022
Metric | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|
Revenue | 409.9M | 409.7M | 331.5M | 324.8M |
Cost of Goods Sold | 170.4M | 174.0M | 140.2M | 142.3M |
Gross Profit | 239.6M | 235.7M | 191.3M | 182.5M |
Gross Margin % | 58.4% | 57.5% | 57.7% | 56.2% |
Operating Expenses | ||||
Research & Development | - | - | - | - |
Selling, General & Administrative | 199.5M | 165.2M | 128.3M | 145.1M |
Other Operating Expenses | - | - | - | - |
Total Operating Expenses | 199.5M | 165.2M | 128.3M | 145.1M |
Operating Income | 39.0M | 69.7M | 61.6M | 36.0M |
Operating Margin % | 9.5% | 17.0% | 18.6% | 11.1% |
Non-Operating Items | ||||
Interest Income | - | - | - | - |
Interest Expense | 25.8M | 85.3M | 52.6M | 41.5M |
Other Non-Operating Income | 49.8M | -67.9M | -6.3M | -3.0M |
Pre-tax Income | 52.7M | -87.2M | 849.0K | -10.0M |
Income Tax | 10.2M | 13.7M | 11.3M | 7.0M |
Effective Tax Rate % | 19.3% | 0.0% | 1,330.5% | 0.0% |
Net Income | 42.5M | -100.9M | -10.4M | -17.0M |
Net Margin % | 10.4% | -24.6% | -3.2% | -5.2% |
Key Metrics | ||||
EBITDA | 44.6M | 8.3M | 74.7M | 50.7M |
EPS (Basic) | $0.42 | $-1.03 | $-0.11 | $-0.17 |
EPS (Diluted) | $0.42 | $-1.03 | $-0.11 | $-0.17 |
Basic Shares Outstanding | 101110000 | 98143000 | 97625000 | 97625000 |
Diluted Shares Outstanding | 101110000 | 98143000 | 97625000 | 97625000 |
Income Statement Trend
Procaps Group S.A Balance Sheet From 2019 to 2022
Metric | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 43.0M | 72.1M | 4.2M | 2.0M |
Short-term Investments | - | - | - | - |
Accounts Receivable | 114.4M | 101.0M | 86.2M | 96.5M |
Inventory | 96.8M | 79.4M | 64.3M | 65.0M |
Other Current Assets | 4.3M | 5.8M | 360.0K | 98.0K |
Total Current Assets | 297.4M | 298.1M | 184.7M | 172.4M |
Non-Current Assets | ||||
Property, Plant & Equipment | 73.7M | 73.8M | 78.2M | 74.1M |
Goodwill | 43.8M | 43.8M | 41.3M | 37.2M |
Intangible Assets | 32.2M | 30.2M | 27.6M | 23.2M |
Long-term Investments | - | - | - | - |
Other Non-Current Assets | 10.1M | 11.6M | 23.6M | 19.3M |
Total Non-Current Assets | 162.7M | 164.1M | 174.8M | 165.3M |
Total Assets | 460.2M | 462.1M | 359.5M | 337.7M |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | 81.5M | 70.2M | 84.5M | 94.2M |
Short-term Debt | 257.5M | 74.6M | 114.8M | 100.0M |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | 11.5M | 7.2M | 11.1M | 9.0M |
Total Current Liabilities | 368.4M | 188.0M | 239.6M | 248.5M |
Non-Current Liabilities | ||||
Long-term Debt | 28.4M | 178.7M | 339.7M | 320.5M |
Deferred Tax Liabilities | 7.8M | 6.1M | 18.9M | 7.7M |
Other Non-Current Liabilities | 46.5M | 104.6M | 3.8M | 5.1M |
Total Non-Current Liabilities | 93.7M | 312.5M | 374.6M | 333.2M |
Total Liabilities | 462.1M | 500.5M | 614.2M | 581.7M |
Equity | ||||
Common Stock | 1.0M | 1.0M | 2.0M | 2.0M |
Retained Earnings | -391.5M | -431.1M | -327.3M | -305.6M |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | -1.9M | -38.3M | -254.7M | -243.9M |
Key Metrics | ||||
Total Debt | 285.9M | 253.4M | 454.5M | 420.4M |
Working Capital | -70.9M | 110.1M | -54.9M | -76.0M |
Balance Sheet Composition
Procaps Group S.A Cash Flow Statement From 2019 to 2022
Metric | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|
Operating Activities | ||||
Net Income | 42.5M | -100.9M | -10.4M | -17.0M |
Depreciation & Amortization | 16.8M | 15.1M | 16.5M | 16.5M |
Stock-Based Compensation | - | - | - | - |
Working Capital Changes | -21.0M | -33.5M | 5.3M | 36.2M |
Operating Cash Flow | 10.6M | 47.0M | 77.1M | 85.7M |
Investing Activities | ||||
Capital Expenditures | -17.9M | -13.3M | -7.1M | -11.5M |
Acquisitions | - | - | - | - |
Investment Purchases | - | - | - | - |
Investment Sales | - | - | - | - |
Investing Cash Flow | -17.9M | -13.3M | -6.9M | -11.5M |
Financing Activities | ||||
Share Repurchases | 0 | -45.0M | 0 | 0 |
Dividends Paid | 0 | 0 | 0 | 0 |
Debt Issuance | 134.4M | 280.8M | 106.7M | 96.4M |
Debt Repayment | -130.9M | -281.2M | -126.3M | -122.5M |
Financing Cash Flow | -3.6M | 75.5M | -25.4M | -30.7M |
Free Cash Flow | -17.5M | 12.8M | 53.0M | 48.6M |
Net Change in Cash | -10.8M | 109.2M | 44.8M | 43.5M |
Cash Flow Trend
Procaps Group S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
1.53
Forward P/E
3.74
Price to Book
3.04
Price to Sales
0.31
PEG Ratio
-0.02
Profitability Ratios
Profit Margin
58.44%
Operating Margin
19.14%
Return on Equity
-2,265.18%
Return on Assets
9.24%
Financial Health
Current Ratio
1.47
Debt to Equity
7.54
Per Share Data
EPS (TTM)
$0.42
Book Value per Share
$0.38
Revenue per Share
$4.05
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
proc | 128.6M | 1.53 | 3.04 | -2,265.18% | 58.44% | 7.54 |
Haleon Plc - ADR | 41.7B | 19.93 | 5.08 | 9.38% | 13.81% | 53.41 |
United Therapeutics | 19.3B | 16.92 | 2.68 | 19.30% | 40.36% | 0.00 |
Ironwood | 230.7M | 92.69 | -0.73 | -0.29% | -2.56% | -1.94 |
BioAge Labs | 212.2M | -0.89 | 0.72 | -35.88% | 0.00% | 2.97 |
Journey Medical | 186.8M | 39.08 | 8.66 | -57.22% | -15.49% | 131.34 |
Financial data is updated regularly. All figures are in the company's reporting currency.